{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:49:00Z","timestamp":1790470140713,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1053\/j.semnuclmed.2006.03.004","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T09:19:17Z","timestamp":1149758357000},"page":"212-227","source":"Crossref","is-referenced-by-count":60,"title":["Adrenal Gland Scintigraphy"],"prefix":"10.1053","volume":"36","author":[{"given":"Anca M.","family":"Avram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine M.","family":"Fig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton D.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2006.03.004_bib1","series-title":"Diagnostic Nuclear Medicine","first-page":"715","article-title":"Adrenal scintigraphy and metaiodobenzylguanidine therapy of neuroendocrine tumors","author":"Gross","year":"2003"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib2","series-title":"Nuclear Medicine in Clinical Diagnosis and Treatment","first-page":"45","article-title":"Adrenocortical scintigraphy","author":"Gross","year":"2004"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib3","series-title":"Endocrinology","first-page":"2425","article-title":"Adrenal gland imaging","author":"Gross","year":"2005"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006231-200203000-00001","article-title":"Is there a future for adrenal scintigraphy?","volume":"23","author":"Gross","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0001-2998(81)80042-6","article-title":"The role of pharmacologic manipulation in adrenal cortical scintigraphy","volume":"11","author":"Gross","year":"1981","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0001-2998(89)80007-8","article-title":"Scintigraphic studies in adrenal hypertension","volume":"19","author":"Gross","year":"1990","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1043-2760(01)00492-1","article-title":"Radioisotope diagnosis and therapy of malignant pheochromocytomas","volume":"12","author":"Shapiro","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1470013","article-title":"Functional scintigraphy of the adrenal gland","volume":"147","author":"Rubello","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib9","first-page":"224","article-title":"Radionuclide imaging of the adrenal cortex","volume":"43","author":"Gross","year":"1999","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM198107023050103","article-title":"Scintigraphic localization of pheochromocytoma","volume":"305","author":"Sisson","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib11","series-title":"Interventional Nuclear Medicine","first-page":"451","article-title":"131I-meta-iodobenzylguaindine (MIBG) adrenal medullary scintigraphy","author":"Shapiro","year":"1983"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib12","first-page":"481","article-title":"Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues","volume":"30","author":"Khafagi","year":"1989","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tem.2005.01.007","article-title":"New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas","volume":"16","author":"Ilias","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib14","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","article-title":"Superiority of 6-18F-fluorodopamine positron emission tomography versus 131-I metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma","volume":"88","author":"Ilias","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","article-title":"Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites","volume":"27","author":"Mamede","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib16","first-page":"685","article-title":"123I-Metaiodobenzylguanidine and 111In-octreotide uptake in benign and malignant pheochromocytomas","volume":"86","author":"Van der Harst","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib17","first-page":"1795","article-title":"18F-FDG PET in characterizing adrenal lesions detected on CT or MRI","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2214\/ajr.172.4.10587135","article-title":"CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing Syndrome","volume":"172","author":"Sohaib","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/jcem-52-6-1156","article-title":"Iodocholesterol adrenal tissue uptake and imaging in adrenal neoplasms","volume":"52","author":"Schteingart","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-109-7-547","article-title":"The localization of abnormal adrenal function in the ACTH-independent Cushing syndrome","volume":"109","author":"Fig","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib21","first-page":"12","article-title":"Dexamethasone suppression adrenal scintigraphy in hyperandrogenism","volume":"22","author":"Gross","year":"1981","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib22","first-page":"472","article-title":"Positive imaging of arrhenoblastoma of the ovary with 131-I-aldosterol","volume":"16","author":"Nakajo","year":"1979","journal-title":"Jpn J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib23","first-page":"287","article-title":"Steroid and gonadotrophin secretion in a patient with a 30-year history of virilization due to a lipoid-cell ovarian tumor","volume":"64","author":"Barkan","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib24","first-page":"332","article-title":"Demonstration of steroid producing gonadal tumors by external scanning with the use of NP-59","volume":"54","author":"Carpenter","year":"1979","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/er.2003-0032","article-title":"Functional imaging of endocrine tumors","volume":"25","author":"Pacak","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib26","first-page":"972","article-title":"Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG","volume":"45","author":"Minn","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-004-1575-0","article-title":"Positron emission tomography imaging of adrenal masses","volume":"31","author":"Zettinig","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib28","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","article-title":"Characterization of adrenal masses using unenhanced CT","volume":"171","author":"Boland","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2214\/ajr.170.3.9490968","article-title":"CT time-attenuation washout curves of adrenal adenomas and nonadenomas","volume":"170","author":"Korobkin","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2214\/ajr.165.3.7645474","article-title":"Distinction between benign and malignant adrenal masses","volume":"165","author":"Outwater","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib32","first-page":"884","article-title":"The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses","volume":"42","author":"Maurea","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib33","first-page":"188","article-title":"Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques","volume":"48","author":"Maurea","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2214\/ajr.168.5.9129444","article-title":"Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-FDG PET","volume":"168","author":"Erasmus","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.rlu.0000124008.68606.4c","article-title":"F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma","volume":"29","author":"Rao","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF03006609","article-title":"High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing\u2019s syndrome","volume":"17","author":"Shimizu","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1536-1632(02)00018-5","article-title":"2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma","volume":"4","author":"Ludwig","year":"2002","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1148\/radiology.202.1.8988215","article-title":"Pheochromocytoma","volume":"202","author":"Mukherjee","year":"1997","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib39","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0033-8389(22)00693-5","article-title":"Pheochromocytoma","volume":"34","author":"Francis","year":"1996","journal-title":"Radiol Clin N Am"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0022-5223(19)38406-5","article-title":"The location of middle mediastinal pheochromocytomas","volume":"87","author":"Shapiro","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","article-title":"Pheochromocytomas","volume":"212","author":"Shulkin","year":"1999","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.004_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/jc.2003-031091","article-title":"Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma","volume":"89","author":"Ilias","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T13:24:42Z","timestamp":1683465882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299806000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0001299806000171"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2006.03.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}